CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Different Fields of Agriculture Implementing Biotechnology

Different Fields of Agriculture...

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Different Fields of Agriculture Implementing Biotechnology

Different Fields of Agriculture...

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Using AI to Prevent Adverse Effects of Immunotherapy

Life Sciences Review | Friday, February 26, 2021
Tweet

Analysis of radiomic features on pre-treatment performed scans could offer a non-invasive way to identify patients.


FREMONT, CA: Until recently, researchers had placed these lung cancer patients into two broad categories, including people who would benefit from immunotherapy and those who likely would not. But the third category of patients called hyper-progressors who would be affected by immunotherapy, including a shortened lifespan after treatment, has begun to emerge. This is a major subset of patients who should potentially avoid immunotherapy completely. Eventually, researchers want this to be integrated into clinical settings to have all the data required to make the call for each patient.


Presently, only about 20 percent of all cancer patients will get value from immunotherapy. This treatment differs from chemotherapy because it uses drugs to support the immune system fight cancer, while chemotherapy leverages drugs to directly kill cancer cells. The CCIPD is a pioneer in detecting, diagnosing, and characterizing many cancers and other diseases by meshing medical imaging, machine learning, and AI. 


CCIPD scientists demonstrated that AI and machine learning could be leveraged to predict which lung cancer patients will benefit from immunotherapy.


This is an important finding because it illustrates that radiomic patterns from routine CT scans can discern three kinds of response in lung cancer patients undergoing immunotherapy treatment--responders, non-responders, and hyper-progressors. In this and previous research, researchers from Case Western Reserve and Cleveland Clinic essentially teach computers to seek and find patterns in CT scans taken when lung cancer is first diagnosed to reveal data that could have been useful if known before treatment. And because many cancer patients have benefitted from immunotherapy, researchers are looking for a better way to identify who would most likely respond to those treatments.


As with any previous cancer research at the CCIPD, researchers again found some significant clues to which patients would be harmed by immunotherapy outside the tumor.  The radiomic features outside the tumor were predictive than those inside the tumor, and alterations in the blood vessels surrounding the nodule were also more predictive.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/using-ai-to-prevent-adverse-effects-of-immunotherapy-nwid-271.html